News

Lobbying World

Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.

Read More »

Lobbying World

Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.

Read More »

Lobbying World

Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.

Read More »

First House office will hold union vote today

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional

Read More »

IP Leaders Join Forces to Counter Anti-IP Narratives

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional

Read More »

IP Luminaries Launch Group To Promote, Defend Innovation

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional

Read More »

Ex-patent officials, U.S. judges join lobbyist for IP policy push

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional

Read More »

Lobbying World

Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating ...

Lobbying World

Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating ...

Lobbying World

Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating ...

First House office will hold union vote today

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should ...

IP Leaders Join Forces to Counter Anti-IP Narratives

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should ...

IP Luminaries Launch Group To Promote, Defend Innovation

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should ...

Ex-patent officials, U.S. judges join lobbyist for IP policy push

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should ...
Scroll to Top